A machine learning model differentiated Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. AUROCs and predictive values for distinguishing Parkinson's from mimics were ...
- Data Presented at the International Congress of Parkinson’s Disease and Movement Disorders - The posters presented from Alterity’s bioMUSE study address the need for incorporating biomarkers as a ...
BIDMC Parkinson’s specialists diagnose and treat atypical Parkinson’s disease, a progressive movement disorder. Learn more.
The structural and functional organization of the brain as shown on MRI can predict the progression of brain atrophy in patients with early-stage, mild Parkinson's disease, according to a study ...
Share on Pinterest Researchers say brain scans can help doctors determine Parkinson’s disease treatments. Popartic/Getty Images Scientists may be able to predict disease progression in people with ...
MELBOURNE, Australia and SAN FRANCISCO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing ...
STOCKHOLM, May 8, 2025 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that regulatory authorities in Spain in Poland have approved the inclusion of Multiple System ...
Medpage Today on MSN
AI Distinguishes Parkinson's Disease From Mimics
An artificial intelligence (AI)-based algorithm differentiated various forms of parkinsonian syndromes based on 3-T MRI.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback